Peripheral blood lymphocytes and T-cell clones produced nanogram quantities of the chemokines RANTES, GRO-o and lymphotactin did not augment the development of motile forms including the size and appearance of the pseudopodia activity of the T-leukemia cell lines. The T-cell lines migrated spontaneously on/to fibronectin in a Boyden chamber assay system. Chemokines augmented the migration of the T-leukemia cell lines on fibronectin in the Boyden system in a chemotactic fashion with peak responses at 10 to 50 ng/ml. Thus, the production of chemokines is defective, in neoplastic T-lymphocytes. The defective chemokine production does not seem to play any major role for the basic locomotor capacity of the cells but may modulate the responsiveness to exogenous chemokines.
INTRODUCTION
T-lymphocytes infiltrate tissues during inflammatory conditions of autoimmune and allergic origin and after neoplastic transformation as in Sezary's syndrome and Mycosis Fungoides (1) (2) (3) . Since the capacity of T-lymphocytes to infiltrate plays a fundamental role in a variety of disease processes it is important to elucidate the regulation of T-cell infiltration. T-leukemia cell lines representing different stages of differentiation provide useful tools for this purpose. Furthermore, it is also important to elucidate whether motility per se or migration on tissue components is normal or altered in neoplastic conditions affecting T-cells. The present work focus on basic locomotor capacity and migration of T-leukemia cell lines on extracellular matrix (ECM) components.
The capacity of T-lymphocytes to migrate and infiltrate depends on the coordination of locomotor properties per se and adhesive interactions with endothelia and components of the extracellular matrix (ECM). T-cell infiltration comprises the adhesion of circulating lymphocytes to vascular endothelium followed by transendothelial passage and migration through the ECM (4-6). To enter sites of inflammation circulating lymphocytes use 2(LFA-1) and [1 (4 and (19, 20, 26, 27 
MATERIALS AND METHODS

Chemicals
The following chemicals were purchased: collagen type IV and laminin (Sigma chemicals Co., St. Louis, MO). Human plasma fibronectin was purified using affinity chromatography-gelatin sepharose 4B (Pharmacia Biotech., Sollentuna, Sweden). (16) .
The neoplastic T-cell lines are immortalized ALL, except Hut-78 which is a Sezary's syndrome (42) . The T-cell clones require antigen stimulation and IL-2 and IL-4, Cells used in the different studies were cultured in 50 ml or 250 ml Falcon tissue culture flasks (Becton Dickinson Labware, Franklin Lakes, NJ). PBL, P 30 (T-blast I), CCRF CEM (T-blast II), Jurkat (T-blast III), MOLT 4 (T-blast III), PEER (T-blast IV) CCRF HSB2 (T-blast IV) and HuT 78 (T-blast V) were cultured in RPMI-medium 1640 (Gibco Ltd, Paisley, Scotland) with additives: 10 % heat-inactivated FCS (Gibco Ltd), 2mM L-glutamine (Seromed, Berlin, Germany), 50 
RESULTS
Chemokine production by normal and neoplastic
T lymphocytes
The production of various chemokines by peripheral blood lymphocytes, T-cell clones and various neoplastic T lymphocyte cell lines representing different stages of T-cell differentiation was compared. The production of chemokines was determined in conditioned media using specific ELISA assays. It is evident from the ELISA assays shown in table I that the blood T-cells and a representative T-cell clone produced and released chemokines including RANTES, MIP-1 and , MCP-1, IL-8 and GRO-into the culture medium. In addition, the motogenic cytokine HGF was detected in conditioned medium from the T-cell clone AF 24 NA NA The concentration of chemokines and cytokines in conditioned media from different T-leukemia cell lines, T cell elones and PBL was analysed The media from the leukemia cell lines were conditioned for 72 hrs whereas the medium from the normal T-cell clone and PBL was conditioned for 48 hrs. The results show that the leukemia T-cell lines studied either did not produce or merely produced very low levels of chemokines or motogenic cytokines while the normal T-cell clone produced a considerable amount of IL-8, MCP-1, MIP-la, MIP-19, RANTES and HGE (10, (19) (20) (21) (23) (24) (25) (26) (27) 29 ) (data not shown). However, it can be seen in fig 2 that the chemokines did not augment the number of motile forms. Thus, the chemokines did not exert any obvious potentiating effect on the motile shape of the cells or on the development of pseudopodia. Furthermore, in some cases chemokines seemed to decrease the number of motile cells.
DISCUSSION
The major conclusion from the present study is that T-leukemia cell lines seem to have defective chemokine production. The data presented in this report thus establish that antigen-specific T-cell clones (table I) However, in spite of the fact that the T-leukemia cell lines did not produce chemokines this defective chemokine production did not seem to influence the basic locomotor capacity of the cells .defined as development of motile forms and pseudopodia. Noteworthy, exogenous chemokines presented in the lower well of Boyden chambers promoted migration of T-leukemia cell lines showing that they possess capacity to respond to chemokines.
The T-leukemia cell lines showed peak migratory responses at lower chemokine concentrations than the "normal" T-cell clone. The difference in optimal chemokine concentrations for a motile response between separate cell types including normal and neoplastic T lymphocytes is not understood. Normal blood T-cells show maximal cytokine responses at 1 ng/ml and RANTES attract monocytes optimally at a concentration of 100 ng/ml (49 (26) .
The present data point to the possibility that normal and neoplastic T lymphocytes may differ in their responses to chemokines although this needs further investigation. Such investigations should focus on the influence of continuous chemokine exposure on the expression of chemokine receptors by T-leukemia cells lacking endogenous chemokines. Does such ligand exposure modulate chemokine receptor expression per se or the sensitivity of chemokine receptors to their ligands? Understanding of possible differences in the mechanisms of chemokine action between normal and neoplastic T lymphocytes probably requires more experimental information concerning chemokine receptors in the same cells.
The fact that T-leukemia cells do not produce chemokines and other motogenic cytokines implies that they lack a regulatory system of endogenous mediators of migration which is present in normal T-cells. Normal T-cell clones, as observed in this study, can migrate chemotactically to their own chemokines. In non-lymphoid cell systems several autocrine motility factors have been described and characterized (50, 51) . These have been proposed to induce cell motility in normal situations such as healing and embryogenesis and to confer metastatic capabilities on neoplastic cells. However, a possible consequence of the lack of endogenous chemokines may be that T-leukemia cells display hyperresponsiveness to environmental chemokines. 
